Doctors Encouraged By Antibody Treatments For COVID-19

Nurse Janet Gilleran prepares to treat COVID-19 patient Mike Mokler with bamlanivimab, a monoclonal antibody drug from Eli Lilly, at the Respiratory Infection Clinic of Tufts Medical Center in Boston on Dec. 31, 2020.

While logistical challenges have hampered use of antibody drugs to treat people with mild-to-moderate COVID-19, recent results show the medicines can be worthwhile.

(Image credit: Craig F. Walker/Boston Globe via Getty Images)

You May Also Like